• News
  • SAN DIEGO
  • BioTech

Organovo partners with Autodesk to develop 3-D bioprinting software

Related Special Reports

San Diego-based Organovo Holdings Inc., a designer and manufacturer of three-dimensional human tissues for medical research, is working with researchers at Autodesk Inc. to create the first 3-D design software for bioprinting, the company announced.

According to a release, Autodesk, a specialist in cloud-based design and engineering software, regularly collaborates with researchers at universities around the world. The private collaboration announced Tuesday will produce a software that will be used to control Organovo's NovoGen MMX bioprinter.

"Autodesk is an excellent partner for Organovo in developing new software for 3-D bioprinters," Keith Murphy, chairman and CEO at Organovo, said. "This relationship will lead to advances in bioprinting, including both greater flexibility and throughput internally, and the potential long-term ability for customers to design their own 3-D tissues for production by Organovo."

Jeff Kowalski, senior vice president and chief technology officer at Autodesk, called it a blend of engineering, biology and 3-D printing, making it a natural fit for Autodesk.

Organovo's 3-D bioprinting technology is used to create living human tissues that are three-dimensional, architecturally correct, and made entirely of living human cells. The resulting structures can function like native human tissues, and represent an opportunity for advancement in medical research, drug discovery and development, and in the future, surgical therapies and transplantation.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Organovo Holdings Inc.

Company Website

6275 Nancy Ridge Dr. Ste., 110
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ONVO
3.25
  -0.03  
- 0.91%
715,412,000
7.68
1.9

Organovo Holdings Inc. Executive(s):

Keith Murphy

  • Chairman, Chief Executive Officer

Barry Michaels

  • Chief Financial Officer